Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling.
about
ERBB3-mediated regulation of Bergmann glia proliferation in cerebellar lamination.PI3K and cancer: lessons, challenges and opportunitiesRecent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical developmentDeregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.FoxO3 coordinates metabolic pathways to maintain redox balance in neural stem cellsEnhanced PI3K p110α signaling confers acquired lapatinib resistance that can be effectively reversed by a p110α-selective PI3K inhibitor.PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for breast cancer therapies?PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance.Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.PI3Kα is essential for the recovery from Cre/tamoxifen cardiotoxicity and in myocardial insulin signalling but is not required for normal myocardial contractility in the adult heart.
P2860
Q27345740-669E4F1D-8EA8-4E48-98A4-A0E6E7328993Q30080017-6178E371-8066-41FB-8F4E-6EBE81AEE6DCQ33776641-550853F7-2FE5-40F7-A14F-5CFA60DEB8DAQ34103963-739D78E7-3C07-4B88-A436-8B168128D278Q36103879-78A50BFA-5441-4766-B183-D3E545CD301EQ37217384-3EAD7B8B-1EAE-496E-A179-547D27854ACAQ37517706-4A080B56-FF22-43A7-9B3A-B8908918DA6EQ38259259-C088A449-598C-4C31-8C2E-DC6BEA33906CQ39036088-A9D4A5DA-4B60-4805-B770-E029922A4938Q47203450-D8BE346A-7833-4B12-8E6B-D972CCDDBAAAQ51308924-8757089B-A31C-45D4-B5E1-DBF37444AD87
P2860
Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Conditional loss of ErbB3 dela ...... gene expression, or signaling.
@en
type
label
Conditional loss of ErbB3 dela ...... gene expression, or signaling.
@en
prefLabel
Conditional loss of ErbB3 dela ...... gene expression, or signaling.
@en
P2093
P2860
P50
P1433
P1476
Conditional loss of ErbB3 dela ...... gene expression, or signaling
@en
P2093
Adam D Pfefferle
Brent N Rexer
Carlos L Arteaga
Christian D Young
Hailing Cheng
Jean J Zhao
María G Kuba
Rebecca S Cook
Violeta Sánchez
P2860
P304
P356
10.1158/0008-5472.CAN-12-4579
P407
P577
2013-04-30T00:00:00Z